Marlowe PLC Transaction in Own Shares

RNS Number : 2186P

Marlowe PLC

09 December 2024

 

9 December 2024

 

Marlowe plc

 

Transaction in Own Shares

 

Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical services, announces that, in accordance with the terms of its share buyback programme announced on 22 May 2024, the Company has purchased 500,000 ordinary shares of 50 pence each in the capital of the Company (the "Shares") in the market at a volume weighted average price of 319.0 pence per Share through Cavendish Capital Markets Limited ("Cavendish"). The Shares acquired will, in due course, be cancelled.

 

 

Aggregated Information

 

Date of Purchase:	06/12/2024
Aggregate Number of Shares Purchased:	500,000
Lowest Price Paid per Share (pence):	319.0
Highest Price Paid per Share (pence):	319.0
Volume-Weighted Average Price Paid per Share (pence):	319.0

 

 

Following the cancellation of Shares, Marlowe will have 84,558,208 ordinary shares of 50 pence each in issue and no ordinary shares are held in treasury. This figure 84,558,208 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Individual Transactions
Number of Shares purchased	Transaction price (pence per Share)	Time of transaction	Venue
500,000	319.0	10.28	AIMX

 

For further information:
Marlowe plc
Lord Ashcroft, Interim Non-Executive Chair Adam Councell, Chief Financial Officer Benjamin Tucker, Head of Investor Relations & Strategy	www.marloweplc.com Tel: [phone] [e-mail]
Cavendish Capital Markets Limited (Nominated Adviser & Broker)
Ben Jeynes George Lawson	Tel: [phone]
FTI Consulting
Nick Hasell Alex Le May	Tel: [phone]

 

About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSBRBDDLGGDGSL